-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Is social media suitable for patient recruitment?
Wolfgang Eglmeier
Clinical Trail Perspective: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Endocrine resistance: mechanisms and therapeutic targets
Senthil Damodaran, Sarmila Majumder, Bhuvaneswari Ramaswamy
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Paola Tomassetti, Monica Cevenini, Elena Guidetti, Giulia Cacciari, Maria Luigia Cipollini, Elena Galassi, Maria Camilla Fabbri, Francesca Nori, Davide Campana, Roberto Corinaldesi ,Roberto De Giorgio
Review: Clinical Trail Outcomes: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation
-
Opportunities for innovation in the design and execution of clinical trials
John J Orloff, Jeffrey Kralstein
Editorial: Clinical Investigation